These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 28160564)
21. Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis. Eissa S; Matboli M; Essawy NO; Kotb YM Tumour Biol; 2015 Dec; 36(12):9545-52. PubMed ID: 26138586 [TBL] [Abstract][Full Text] [Related]
22. Lectin-induced agglutination method of urinary exosomes isolation followed by mi-RNA analysis: Application for prostate cancer diagnostic. Samsonov R; Shtam T; Burdakov V; Glotov A; Tsyrlina E; Berstein L; Nosov A; Evtushenko V; Filatov M; Malek A Prostate; 2016 Jan; 76(1):68-79. PubMed ID: 26417675 [TBL] [Abstract][Full Text] [Related]
23. Serum extracellular vesicular miR-21-5p is a predictor of the prognosis in idiopathic pulmonary fibrosis. Makiguchi T; Yamada M; Yoshioka Y; Sugiura H; Koarai A; Chiba S; Fujino N; Tojo Y; Ota C; Kubo H; Kobayashi S; Yanai M; Shimura S; Ochiya T; Ichinose M Respir Res; 2016 Sep; 17(1):110. PubMed ID: 27596748 [TBL] [Abstract][Full Text] [Related]
24. Feasibility of urinary microRNA detection in breast cancer patients and its potential as an innovative non-invasive biomarker. Erbes T; Hirschfeld M; Rücker G; Jaeger M; Boas J; Iborra S; Mayer S; Gitsch G; Stickeler E BMC Cancer; 2015 Mar; 15():193. PubMed ID: 25886191 [TBL] [Abstract][Full Text] [Related]
25. Extracellular Vesicles and Their Role in Urologic Malignancies. Junker K; Heinzelmann J; Beckham C; Ochiya T; Jenster G Eur Urol; 2016 Aug; 70(2):323-31. PubMed ID: 26924769 [TBL] [Abstract][Full Text] [Related]
26. Urinary Extracellular Vesicles and Their miRNA Cargo in Patients with Fabry Nephropathy. Levstek T; Mlinšek T; Holcar M; Goričar K; Lenassi M; Dolžan V; Vujkovac B; Trebušak Podkrajšek K Genes (Basel); 2021 Jul; 12(7):. PubMed ID: 34356073 [TBL] [Abstract][Full Text] [Related]
27. Comparison between cytospin and liquid-based cytology in urine specimens classified according to the Paris System for Reporting Urinary Cytology. Straccia P; Bizzarro T; Fadda G; Pierconti F Cancer Cytopathol; 2016 Jul; 124(7):519-23. PubMed ID: 26989867 [TBL] [Abstract][Full Text] [Related]
28. Non-coding RNAs as biomarkers in liquid biopsies with a special emphasis on extracellular vesicles in urological malignancies. Zeuschner P; Linxweiler J; Junker K Expert Rev Mol Diagn; 2020 Feb; 20(2):151-167. PubMed ID: 31499007 [No Abstract] [Full Text] [Related]
29. Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis. Theodorescu D; Wittke S; Ross MM; Walden M; Conaway M; Just I; Mischak H; Frierson HF Lancet Oncol; 2006 Mar; 7(3):230-40. PubMed ID: 16510332 [TBL] [Abstract][Full Text] [Related]
30. Urinary exosomal viral microRNA as a marker of BK virus nephropathy in kidney transplant recipients. Kim MH; Lee YH; Seo JW; Moon H; Kim JS; Kim YG; Jeong KH; Moon JY; Lee TW; Ihm CG; Kim CD; Park JB; Chung BH; Kim YH; Lee SH PLoS One; 2017; 12(12):e0190068. PubMed ID: 29267352 [TBL] [Abstract][Full Text] [Related]
31. Implications of urinary basic fibroblast growth factor excretion in patients with urothelial carcinoma. Chow NH; Chang CJ; Yeh TM; Chan SH; Tzai TS; Lin JS Clin Sci (Lond); 1996 Feb; 90(2):127-33. PubMed ID: 8829882 [TBL] [Abstract][Full Text] [Related]
32. Direct quantitative detection for cell-free miR-155 in urine: a potential role in diagnosis and prognosis for non-muscle invasive bladder cancer. Zhang X; Zhang Y; Liu X; Fang A; Wang J; Yang Y; Wang L; Du L; Wang C Oncotarget; 2016 Jan; 7(3):3255-66. PubMed ID: 26657502 [TBL] [Abstract][Full Text] [Related]
33. H19 non-coding RNA in urine cells detects urothelial carcinoma: a pilot study. Gielchinsky I; Gilon M; Abu-Lail R; Matouk I; Hochberg A; Gofrit ON; Ben-Dov IZ Biomarkers; 2017 Nov; 22(7):661-666. PubMed ID: 28067543 [TBL] [Abstract][Full Text] [Related]
34. Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer. Mengual L; Lozano JJ; Ingelmo-Torres M; Gazquez C; Ribal MJ; Alcaraz A Int J Cancer; 2013 Dec; 133(11):2631-41. PubMed ID: 23686449 [TBL] [Abstract][Full Text] [Related]
35. Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profile. Vermassen T; D'Herde K; Jacobus D; Van Praet C; Poelaert F; Lumen N; Callewaert N; Decaestecker K; Villeirs G; Hoebeke P; Van Belle S; Rottey S; Delanghe J J Clin Pathol; 2017 Oct; 70(10):838-846. PubMed ID: 28360190 [TBL] [Abstract][Full Text] [Related]
36. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer. Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145 [TBL] [Abstract][Full Text] [Related]
37. ProEx C as an adjunct marker to improve cytological detection of urothelial carcinoma in urinary specimens. Moatamed NA; Rao JY; Alexanian S; Cobarrubias M; Levin M; Lu D; Apple SK Cancer Cytopathol; 2013 Jun; 121(6):320-8. PubMed ID: 23364848 [TBL] [Abstract][Full Text] [Related]
38. Cytohistologic correlation of recurrent urothelial carcinoma detected in urinary diversion specimens. Xing J; Roy S; Monaco SE; Pantanowitz L Cancer Cytopathol; 2017 Feb; 125(2):120-127. PubMed ID: 27741389 [TBL] [Abstract][Full Text] [Related]
39. Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications. Kurtis B; Zhuge J; Ojaimi C; Ye F; Cai D; Zhang D; Fallon JT; Zhong M Ann Diagn Pathol; 2016 Apr; 21():7-11. PubMed ID: 27040924 [TBL] [Abstract][Full Text] [Related]
40. The MicroRNA Prediction Models as Ancillary Diagnosis Biomarkers for Urothelial Carcinoma in Patients With Chronic Kidney Disease. Li AL; Chou CY; Chen CL; Wu KL; Lin SC; Chen HC; Wang MC; Chang CC; Hsu BG; Wu MS; Ma N; Huang CC Front Med (Lausanne); 2021; 8():726214. PubMed ID: 34660637 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]